VEENAT 100mg

Each capsule contains Imatinib Mesylate equivalent to Imatinib 100mg.

Imatinib Mesylate is a protein - tyrosine kinase inhibitor that inhibits the Bcr-Abl tyrosine kinase, the constitutive abnormal tyrosine kinase created by the Philadelphia Chromosome abnormality in Chronic Myeloid Leukemia (CML).

VEENAT (Imatinib Mesylate) is indicated for the treatment of patients with Philadelphia Chromosome positive Chronic Myeloid Leukemia (CML) in blast crisis, accelerated phase, or in chronic phase.